Columbia Financial (NASDAQ:CLBK) reported a significant return to profitability for both the fourth quarter and the full year of 2025, fueled by a sharp expansion in net interest margin (NIM) and a strategic balance sheet repositioning initiated in late 2024.
Hess Midstream (NYSE:HESM) reported fourth-quarter 2025 results on Monday that met analyst earnings expectations but fell slightly short on revenue, as severe winter weather in the Bakken region hampered throughput volumes.
Equinor (NYSE:EQNR) has agreed to divest its entire onshore portfolio in Argentina’s prolific Vaca Muerta shale basin to Vista Energy (NYSE:VIST) in a transaction valued at approximately $1.1 billion.
ImmunityBio (NASDAQ:IBRX) announced Monday the launch of ResQ215B, a Phase 2 clinical study evaluating a novel, outpatient immunotherapy combination for patients with indolent B-cell non-Hodgkin lymphoma (iNHL), including Waldenström’s Macroglobulinemia.
Devon Energy (NYSE:DVN) and Coterra Energy (NYSE:CTRA) announced a definitive agreement on Monday to combine in an all-stock merger, creating a premier independent shale producer with a dominant footprint in the Delaware Basin.
Gibraltar Industries (NASDAQ:ROCK) announced Monday that it has finalized its acquisition of OmniMax International from funds managed by Strategic Value Partners.
Sierra Bancorp (NASDAQ:BSRR), the parent company of Bank of the Sierra, reported fourth-quarter net income of $12.9 million on Monday, delivering an earnings surprise that outpaced Wall Street forecasts.
Heritage Financial (NASDAQ:HFWA) announced Monday that it has finalized its acquisition of Olympic Bancorp, a move that creates one of the most significant community banking platforms in the Pacific Northwest.
TuHURA Biosciences (NASDAQ:HURA) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead immune-priming candidate, IFx-2.0, for the treatment of stage IIB to stage IV cutaneous melanoma.
TransUnion (NYSE:TRU) signed a definitive agreement on Monday to acquire the mobile division of RealNetworks, a move aimed at integrating advanced artificial intelligence and machine learning into its growing communications and fraud-prevention suite.
Huntington Bancshares (NASDAQ:HBAN) completed its merger with Cadence Bank on Monday, creating a $279 billion regional powerhouse and marking one of the most significant consolidations in the U.S. banking sector this year.
Stoneridge (NYSE SRI) finalized the sale of its Control Devices segment to an affiliate of Center Rock Capital Partners on Friday, marking a definitive shift toward its high-growth electronics and safety platforms.
